ArticleAcute medicine & surgery
External validation of the sICOP score for early mortality in mechanically ventilated patients with COVID-19.
Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- External validation of the sICOP score for early mortality in mechanically ventilated patients with COVID-19.Acute medicine & surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: The aim of this study was to externally validate the prognostic score for mechanically ventilated patients with novel coronavirus disease-2019 (COVID-19), the simplified intubated COVID-19 predictive (sICOP) score. Methods: This was a retrospective, multicenter, observational study conducted using the database registry of patients with moderate-to-severe COVID-19 at 66 hospitals in Japan. The data of 146 mechanically ventilated COVID-19 patients were analyzed. Results: The areas under the curve (AUC) of the sICOP score for predicting the 28-day mortality and in-hospital mortality were 0.81 (0.73-0.89) and 0.74 (0.65-0.83), respectively. The AUC of the score was statistically significantly higher than that of the SOFA score for 28-day mortality and in-hospital mortality (28-day mortality; 0.82 [0.73-0.90] vs. 0.58 [0.46-0.70], Conclusion: We found that the sICOP score was useful for predicting the 28-day mortality with excellent accuracy in mechanically ventilated COVID-19 patients in the era prior to the widespread availability of vaccines and effective antivirals. Validation of the score would be needed by using data from recent waves.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.